Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 9 min ago
PreprintCC BY-NC-NDmedRxiv

Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine

  1. 1Burnet Institute, Melbourne, Australia

Abstract

The RTS,S vaccine provides moderate protection against malaria in children, which may be due in part to environmental factors. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are prevalent in Africa and potentially contribute to suboptimal vaccine responses. We evaluated whether latent CMV/EBV infections impact RTS,S-induced antibodies in 314 vaccinated children aged 5-29 months in West Africa. While no strong associations were observed for CMV, children seropositive for EBV had lower antigen-specific IgG and IgA, which have been linked with protective malaria immunity. These results may partly explain why malaria vaccines are suboptimal in populations where early CMV/EBV infections are prevalent.

Related

  1. Protective effects of heat shock protein 70 induction against global warming by using oriental bezoar and ginseng
    E. Inoue, T. Tsubonoya, Y. Shimizu +2
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  2. Influenza A(H3N2) Subclade K During the 2025-26 Season and Differential Humoral Responses in Vaccinated Individuals Versus Vaccinated Convalescents in Israel.
    Ital Nemet, Neta S Zuckerman, Nofar Atari +9
    VaccinesPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Protective effects of cannabidiol against acute stress: behavioral responses and corticosterone concentrations in female Wistar rats
    Matjaž Uršič, Mina Cansu Karaer, Alenka Gregorič +2
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Post-treatment serologic, cerebrospinal fluid, MRI, and salivary antibody responses in HIV-negative neurosyphilis: a retrospective study
    Xuan Long, Weipeng Lin, Jiahui Shen +3
    Frontiers in neurologyPeer-reviewedCC BYFull textNeurologyEurope PMC
  5. Effects of regular exercise on neutrophil functions, oxidative stress parameters and antibody responses against 4-hydroxy-2-nonenal adducts in middle aged humans
    Sasaki, Soichiro, Matsuura, Takayuki, Takahashi, Rei +7
    PubMedPeer-reviewedLicence not stated16 citedPhysiologyOpenAlex
BibTeX
@misc{harris2026epsteinbarr,
  title = {{Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine}},
  author = {A. W. Harris and A. Thomas and J.-B. Ouedraogo and H. Tinto and I. Zongo and A. Dicko and I. Sagara and D. Chandramohan and B. Greenwood and L. Kurtovic and J. Beeson},
  howpublished = {medRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.03.26367212},
  url = {https://www.medrxiv.org/content/10.64898/2026.11.03.26367212v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Epstein-Barr virus influences the induction of protective antibody responses in young African children vaccinated with the RTS,S malaria vaccine
AU  - A. W. Harris
AU  - A. Thomas
AU  - J.-B. Ouedraogo
AU  - H. Tinto
AU  - I. Zongo
AU  - A. Dicko
AU  - I. Sagara
AU  - D. Chandramohan
AU  - B. Greenwood
AU  - L. Kurtovic
AU  - J. Beeson
PY  - 2026
DA  - 2026/11/03
PB  - medRxiv
DO  - 10.64898/2026.11.03.26367212
UR  - https://www.medrxiv.org/content/10.64898/2026.11.03.26367212v1
AB  - The RTS,S vaccine provides moderate protection against malaria in children, which may be due in part to environmental factors. Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections are prevalent in Africa and potentially contribute to suboptimal vaccine responses. We evaluated whether latent CMV/EBV infections impact RTS,S-induced antibodies in 314 vaccinated children aged 5-29 months in West Africa. While no strong associations were observed for CMV, children seropositive for EBV had lower antigen-specific IgG and IgA, which have been linked with protective malaria immunity. These results may partly explain why malaria vaccines are suboptimal in populations where early CMV/EBV infections are prevalent.
ER  -